Hopewell Therapeutics' new class of mRNA therapies, using organ and cell-specific biodegradable lipid nanoparticles (LNPs) to address unmet medical needs, including immuno-oncology and regenerative medicine.
Location: United States, Massachusetts, Woburn
Total raised: $25M
Investors 1
| Date | Name | Website |
| 13.10.2022 | IMO Ventur... | imo.vc/ |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.06.2023 | Seed | $25M | Massachuse... |
Mentions in press and media 2
| Date | Title | Description |
| 07.06.2023 | Hopewell Therapeutics Raises $25M in Seed Financing | Hopewell Therapeutics, a Woburn, MA-based biotechnology company with a differentiated lipid nanoparticle platform harnessing unique ionizable lipid chemistry, announced a Seed Financing of up to $25m. The round has been supported by Mass Av... |
| - | Hopewell Therapeutics | “Hopewell Therapeutics' new class of mRNA therapies, using organ and cell-specific biodegradable lipid nanoparticles (LNPs) to address unmet medical needs, including immuno-oncology and regenerative medicine. ” |